Funder Development Partnering Agreement Post author:GHIAA Admin Post published:October 5, 2022 Post category: Continue ReadingFunder Development Partnering Agreement
NIH – MPP, COVID-19 Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement
NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
MPP – Pfizer, Sutezolid License Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingMPP – Pfizer, Sutezolid License Agreement
Funder Development Partnering Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingFunder Development Partnering Agreement
Funder Development Partnering Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingFunder Development Partnering Agreement